Published in Front Biosci (Landmark Ed) on January 01, 2009
Human papillomavirus molecular biology and disease association. Rev Med Virol (2015) 1.09
E2 proteins of high risk human papillomaviruses down-modulate STING and IFN-κ transcription in keratinocytes. PLoS One (2014) 0.99
Unusual characteristics of the DNA binding domain of epigenetic regulatory protein MeCP2 determine its binding specificity. Biochemistry (2014) 0.93
Whole genome sequencing and evolutionary analysis of human papillomavirus type 16 in central China. PLoS One (2012) 0.90
Evolution of human papillomavirus carcinogenicity. Adv Virus Res (2010) 0.83
Detection and analysis of human papillomavirus (HPV) DNA in breast cancer patients by an effective method of HPV capture. PLoS One (2014) 0.80
In vivo Antitumor Effect of an HPV-specific Promoter driving IL-12 Expression in an HPV 16-positive Murine Model of Cervical Cancer. J Cancer (2016) 0.75
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet (2000) 69.26
Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol (1993) 64.61
Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A (2001) 42.14
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
Classification of papillomaviruses. Virology (2004) 14.16
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (1985) 11.11
Main-chain bond lengths and bond angles in protein structures. J Mol Biol (1993) 9.80
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol (2005) 9.67
Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: the roles of ion association or release, screening, and ion effects on water activity. Q Rev Biophys (1978) 9.44
Human papillomavirus type 16 DNA sequence. Virology (1985) 9.44
Recognition of errors in three-dimensional structures of proteins. Proteins (1993) 9.38
Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation. Comput Appl Biosci (1993) 9.38
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006) 7.83
Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol (2003) 7.15
Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol (1985) 6.18
Ion effects on ligand-nucleic acid interactions. J Mol Biol (1976) 5.52
Multiple protein sequence alignment from tertiary structure comparison: assignment of global and residue confidence levels. Proteins (1992) 4.92
The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol (1985) 4.82
Recognition of a DNA operator by the repressor of phage 434: a view at high resolution. Science (1988) 4.60
Human papillomavirus 1a complete DNA sequence: a novel type of genome organization among papovaviridae. EMBO J (1982) 4.13
Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature (1992) 4.12
Human papillomavirus immortalization and transformation functions. Virus Res (2002) 3.58
The papillomavirus E2 regulatory proteins. J Biol Chem (1991) 3.27
The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity. EMBO J (1988) 3.20
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine (2006) 2.78
The B-DNA dodecamer at high resolution reveals a spine of water on sodium. Biochemistry (1998) 2.68
Beta-turns and their distortions: a proposed new nomenclature. Protein Eng (1990) 2.67
Effect of non-contacted bases on the affinity of 434 operator for 434 repressor and Cro. Nature (1987) 2.49
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol (1997) 2.40
Prophylactic human papillomavirus vaccines. J Clin Invest (2006) 2.36
Intrinsic phi, psi propensities of amino acids, derived from the coil regions of known structures. Nat Struct Biol (1995) 2.32
Interpretation of monovalent and divalent cation effects on the lac repressor-operator interaction. Biochemistry (1977) 2.23
Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol (2006) 2.22
Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst (1997) 2.06
Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res (2004) 1.90
The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2. Genes Dev (2004) 1.90
The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J Virol (2005) 1.86
Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst (2001) 1.86
Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J (1997) 1.85
DNA bending by an adenine--thymine tract and its role in gene regulation. Proc Natl Acad Sci U S A (2001) 1.81
Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J Virol (2006) 1.81
Structure of the potassium form of CGCGAATTCGCG: DNA deformation by electrostatic collapse around inorganic cations. Biochemistry (1998) 1.79
Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol (2000) 1.78
The biology of human papillomaviruses: from warts to cancer. Infect Agents Dis (1993) 1.78
Protein-DNA recognition complexes: conservation of structure and binding energy in the transition state. Biopolymers (1997) 1.73
Identification of a novel human papillomavirus (HPV97) related to HPV18 and HPV45. Int J Cancer (2007) 1.68
Localization of ammonium ions in the minor groove of DNA duplexes in solution and the origin of DNA A-tract bending. J Mol Biol (1999) 1.67
DNA A-tract bending in three dimensions: solving the dA4T4 vs. dT4A4 conundrum. Proc Natl Acad Sci U S A (2004) 1.66
DNA structure: what's in charge? J Mol Biol (2000) 1.65
The papillomavirus E2 proteins: structure, function, and biology. Annu Rev Biophys Biomol Struct (2001) 1.63
DNA structure: cations in charge? Curr Opin Struct Biol (1999) 1.61
Two E2 binding sites (E2BS) alone or one E2BS plus an A/T-rich region are minimal requirements for the replication of the human papillomavirus type 11 origin. J Virol (1993) 1.50
Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology (2006) 1.47
Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res (2003) 1.46
Papillomaviruses in human disease: Part II. Molecular biology and immunology of papillomavirus infections and carcinogenesis. Eur J Med (1992) 1.44
Functional interactions between papillomavirus E1 and E2 proteins. J Virol (1997) 1.42
A unified model for the origin of DNA sequence-directed curvature. Biopolymers (2003) 1.41
The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic Acids Res (1992) 1.38
Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol (2003) 1.37
Binding sites and dynamics of ammonium ions in a telomere repeat DNA quadruplex. J Mol Biol (1999) 1.37
The hinge of the human papillomavirus type 11 E2 protein contains major determinants for nuclear localization and nuclear matrix association. J Virol (2000) 1.37
Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses. J Virol (2005) 1.34
The structural basis of DNA target discrimination by papillomavirus E2 proteins. J Biol Chem (2000) 1.32
Biology of human papillomaviruses. Int J Exp Pathol (2001) 1.31
DNA twisting and the effects of non-contacted bases on affinity of 434 operator for 434 repressor. Nature (1992) 1.31
Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature (2000) 1.30
Evolution and physics in comparative protein structure modeling. Acc Chem Res (2002) 1.29
Crystal structure of the human papillomavirus type 18 E2 activation domain. Science (1999) 1.28
DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins. J Mol Biol (1998) 1.27
Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol (2001) 1.26
CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J Virol (1996) 1.26
DNA fine structure and dynamics in crystals and in solution: the impact of BI/BII backbone conformations. Biopolymers (2004) 1.25
Structural code for DNA recognition revealed in crystal structures of papillomavirus E2-DNA targets. Proc Natl Acad Sci U S A (1998) 1.24
Molecular dynamics simulations of B '-DNA: sequence effects on A-tract-induced bending and flexibility. J Mol Biol (2001) 1.23
Predicting indirect readout effects in protein-DNA interactions. Proc Natl Acad Sci U S A (2004) 1.23
Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism. J Mol Biol (1998) 1.23
Beta-hairpins in proteins revisited: lessons for de novo design. Protein Eng (1997) 1.22
Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein. EMBO J (1997) 1.20
Human papillomavirus type 13 and pygmy chimpanzee papillomavirus type 1: comparison of the genome organizations. Virology (1992) 1.18
Two E2 binding sites alone are sufficient to function as the minimal origin of replication of human papillomavirus type 18 DNA. J Virol (1995) 1.18
Crystal structure of the E2 transactivation domain of human papillomavirus type 11 bound to a protein interaction inhibitor. J Biol Chem (2003) 1.17
Human papillomaviruses and their role in cervical cancer. Cell Mol Life Sci (2001) 1.15
Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J Virol (2003) 1.11
The effect of DNA methylation on gene regulation of human papillomaviruses. J Gen Virol (1993) 1.09
Comparative structural and energetic analysis of WW domain-peptide interactions. J Mol Biol (2004) 1.06
Equilibrium dissociation and unfolding of the dimeric human papillomavirus strain-16 E2 DNA-binding domain. Protein Sci (1996) 1.06
E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death. J Virol (2006) 1.03
DNA binding and bending by the human papillomavirus type 16 E2 protein. Recognition of an extended binding site. J Biol Chem (1997) 1.02
Free energy contributions to direct readout of a DNA sequence. J Biol Chem (2005) 1.00
Free-energy component analysis of 40 protein-DNA complexes: a consensus view on the thermodynamics of binding at the molecular level. J Comput Chem (2002) 1.00
Characterization of a novel genital human papillomavirus by overlapping PCR: candHPV86 identified in cervicovaginal cells of a woman with cervical neoplasia. J Gen Virol (2001) 0.99
Vaccination of rabbits with an adenovirus vector expressing the papillomavirus E2 protein leads to clearance of papillomas and infection. J Virol (2004) 0.96
Control of papillomavirus DNA replication and transcription. Semin Cancer Biol (1996) 0.96
Improvement of domain linker prediction by incorporating loop-length-dependent characteristics. Biopolymers (2006) 0.95
Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. J Gen Virol (1999) 0.94
Two patches of amino acids on the E2 DNA binding domain define the surface for interaction with E1. J Virol (2000) 0.94
Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: evidence for flexible DNA-binding regions. Biochemistry (1996) 0.93
Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription. J Gen Virol (2004) 0.92
Comparison of the structure and DNA-binding properties of the E2 proteins from an oncogenic and a non-oncogenic human papillomavirus. J Mol Biol (2003) 0.91
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology (2010) 7.24
Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst (2005) 5.29
The carcinogenicity of human papillomavirus types reflects viral evolution. Virology (2005) 4.72
MODBASE, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Res (2004) 4.54
Protein production and purification. Nat Methods (2008) 3.97
Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst (2010) 3.95
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis (2005) 3.84
Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2008) 3.73
Tools for comparative protein structure modeling and analysis. Nucleic Acids Res (2003) 3.68
Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol (2002) 3.53
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis (2005) 3.46
Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst (2003) 2.81
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ (2009) 2.68
A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst (2005) 2.60
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol (2009) 2.57
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res (2006) 2.33
Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,. Rev Panam Salud Publica (2004) 2.33
CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol (2007) 2.27
Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev (2002) 2.24
Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res (2008) 2.24
Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst (2004) 2.23
High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer (2007) 2.06
Outcome of a workshop on applications of protein models in biomedical research. Structure (2009) 2.05
A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev (2008) 2.01
Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiol Biomarkers Prev (2010) 2.00
Insights into the mechanism of microtubule stabilization by Taxol. Proc Natl Acad Sci U S A (2006) 1.96
PSI-2: structural genomics to cover protein domain family space. Structure (2009) 1.92
Principles of RNA compaction: insights from the equilibrium folding pathway of the P4-P6 RNA domain in monovalent cations. J Mol Biol (2004) 1.90
Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. Am J Epidemiol (2014) 1.88
The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera. J Infect Dis (2011) 1.87
Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA (2005) 1.86
Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Infect Dis (2010) 1.85
Functional roles of aspartate residues of the proton-coupled folate transporter (PCFT-SLC46A1); a D156Y mutation causing hereditary folate malabsorption. Blood (2010) 1.83
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res (2010) 1.82
Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res (2006) 1.82
A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer Epidemiol Biomarkers Prev (2011) 1.82
Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One (2011) 1.80
A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev (2003) 1.80
High-throughput single-nucleotide structural mapping by capillary automated footprinting analysis. Nucleic Acids Res (2008) 1.78
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses. J Exp Med (2011) 1.77
Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol Biomarkers Prev (2004) 1.76
Ancient papillomavirus-host co-speciation in Felidae. Genome Biol (2007) 1.75
Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev (2011) 1.68
Identification of a novel human papillomavirus (HPV97) related to HPV18 and HPV45. Int J Cancer (2007) 1.68
Pentapeptide repeat proteins. Biochemistry (2006) 1.68
Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles. J Infect Dis (2002) 1.66
Post-translational modifications to Toxoplasma gondii alpha- and beta-tubulins include novel C-terminal methylation. J Proteome Res (2010) 1.64
A comparison of cervical and vaginal human papillomavirus. Sex Transm Dis (2007) 1.62
Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. Cancer Res (2006) 1.59
A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol (2011) 1.58
Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. J Infect Dis (2002) 1.58
Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol (2005) 1.57
Predicting disulfide bond connectivity in proteins by correlated mutations analysis. Bioinformatics (2008) 1.57
Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis (2003) 1.57
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica. Cancer Epidemiol Biomarkers Prev (2004) 1.56
High-throughput computational and experimental techniques in structural genomics. Genome Res (2004) 1.55
Structural genomics is the largest contributor of novel structural leverage. J Struct Funct Genomics (2009) 1.52
Concerted binding and bending of DNA by Escherichia coli integration host factor. J Mol Biol (2002) 1.49
Functional classification of immune regulatory proteins. Structure (2013) 1.49
The functional roles of the His247 and His281 residues in folate and proton translocation mediated by the human proton-coupled folate transporter SLC46A1. J Biol Chem (2009) 1.47
Human papillomavirus genome variants. Virology (2013) 1.45
Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. Int J Cancer (2012) 1.44
Primary cilium formation requires von hippel-lindau gene function in renal-derived cells. Cancer Res (2006) 1.44
Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS One (2010) 1.43
Structural genomics of protein phosphatases. J Struct Funct Genomics (2007) 1.40
Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. J Natl Cancer Inst (2012) 1.40
Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics (2002) 1.38
The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. Int J Cancer (2011) 1.38
Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. J Natl Cancer Inst (2012) 1.38
Local kinetic measures of macromolecular structure reveal partitioning among multiple parallel pathways from the earliest steps in the folding of a large RNA molecule. J Mol Biol (2006) 1.38
Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years. Cancer Epidemiol Biomarkers Prev (2010) 1.36
A population-based study of vaginal human papillomavirus infection in hysterectomized women. J Infect Dis (2004) 1.36
Monovalent cations mediate formation of native tertiary structure of the Tetrahymena thermophila ribozyme. Nat Struct Biol (2002) 1.36
Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. J Infect Dis (2009) 1.35
Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. J Infect Dis (2009) 1.35
Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97. J Virol (2008) 1.35
Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses. J Virol (2005) 1.34
Fast Fenton footprinting: a laboratory-based method for the time-resolved analysis of DNA, RNA and proteins. Nucleic Acids Res (2006) 1.33
Concordant exploration of the kinetics of RNA folding from global and local perspectives. J Mol Biol (2005) 1.33
Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.33
Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. Gynecol Oncol (2011) 1.32
Linkage of monovalent and divalent ion binding in the folding of the P4-P6 domain of the Tetrahymena ribozyme. Biochemistry (2002) 1.31
A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study. J Infect Dis (2011) 1.31
Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clin Cancer Res (2009) 1.29
Semiautomated and rapid quantification of nucleic acid footprinting and structure mapping experiments. Nat Protoc (2008) 1.27
Distinct contribution of electrostatics, initial conformational ensemble, and macromolecular stability in RNA folding. Proc Natl Acad Sci U S A (2007) 1.26
Productive folding to the native state by a group II intron ribozyme. J Mol Biol (2002) 1.26
Spatial arrangement of an RNA zipcode identifies mRNAs under post-transcriptional control. Genes Dev (2012) 1.26
Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J Virol (2012) 1.26
Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica. J Infect Dis (2011) 1.25
Monovalent ion-mediated folding of the Tetrahymena thermophila ribozyme. J Mol Biol (2004) 1.24
An alternative route for the folding of large RNAs: apparent two-state folding by a group II intron ribozyme. J Mol Biol (2003) 1.24
A biochemical mechanism for the oncogenic potential of the p110beta catalytic subunit of phosphoinositide 3-kinase. Proc Natl Acad Sci U S A (2010) 1.23
Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions. J Clin Microbiol (2007) 1.22